These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16568440)

  • 21. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
    Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
    Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
    Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R
    Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach.
    Sun Y; Li JY; He JS; Zhou LX; Chen K
    Histopathology; 2005 May; 46(5):505-14. PubMed ID: 15842632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic significance of cyclin A expression in colorectal carcinoma.
    Nozoe T; Inutsuka S; Honda M; Ezaki T; Korenaga D
    J Exp Clin Cancer Res; 2004 Mar; 23(1):127-33. PubMed ID: 15149161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
    Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
    Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
    Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer.
    Corin I; Larsson L; Bergström J; Gustavsson B; Derwinger K
    Acta Oncol; 2010; 49(1):63-9. PubMed ID: 20001501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
    Kleinberg L; Dong HP; Holth A; Risberg B; Trope' CG; Nesland JM; Flørenes VA; Davidson B
    Hum Pathol; 2009 Jun; 40(6):795-806. PubMed ID: 19157506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma.
    Xie D; Lau SH; Sham JS; Wu QL; Fang Y; Liang LZ; Che LH; Zeng YX; Guan XY
    Cancer; 2005 Jan; 103(2):277-83. PubMed ID: 15578711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients.
    Mehdipour P; Pirouzpanah S; Sarafnejad A; Atri M; Shahrestani ST; Haidari M
    Cell Biol Int; 2009 Oct; 33(10):1050-6. PubMed ID: 19555767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.
    Barbieri F; Lorenzi P; Ragni N; Schettini G; Bruzzo C; Pedullà F; Alama A
    Oncology; 2004; 66(4):310-5. PubMed ID: 15218299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.